NYMOX PHARMACEUTICAL CORPORATION (NYMXF) Operating cash flow 2015–2024
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$2.6MFY2024 · since FY2015: -$3.8M → -$2.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$2.6M | +35.9% |
| FY2023 | -$4.1M | +22.1% |
| FY2022 | -$5.2M | +47.0% |
| FY2021 | -$9.8M | +2.2% |
| FY2020 | -$10.0M | -35.1% |
| FY2019 | -$7.4M | +4.8% |
| FY2018 | -$7.8M | -25.7% |
| FY2017 | -$6.2M | -37.8% |
| FY2016 | -$4.5M | -20.0% |
| FY2015 | -$3.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NYMXF financial trends
NYMXF RevenueNYMXF Net incomeNYMXF Net marginNYMXF Gross profitNYMXF Gross marginNYMXF Operating incomeNYMXF Operating marginNYMXF Free cash flowNYMXF Capital expendituresNYMXF Return on equityNYMXF Stock buybacksNYMXF Dividends paidNYMXF Total assetsNYMXF Total liabilitiesNYMXF Shareholders’ equityNYMXF overview →